1. Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications
- Author
-
Elena Azzini, Javad Sharifi-Rad, Ahmet Beyatli, Yasaman Taheri, Hafiz Ansar Rasul Suleria, William N. Setzer, Anuj Kumar, Alfred Maroyi, Prabhakar Semwal, Miquel Martorell, G. A. Seitimova, Sakshi Painuli, Oksana Sytar, Balakyz Yeskaliyeva, Bahare Salehi, Natália Martins, and Instituto de Investigação e Inovação em Saúde
- Subjects
Antineoplastic Agents / pharmacology ,Review ,Pharmacology ,Antioxidants ,chemistry.chemical_compound ,0302 clinical medicine ,Anti-Infective Agents ,Neuroprotective Agents / pharmacology ,Medicine ,Antioxidants / chemistry ,Cancer ,0303 health sciences ,Molecular Structure ,Myricetin ,Diabetes ,lcsh:Other systems of medicine ,Antimicrobial ,Cardiovascular disease ,Neuroprotection ,Neuroprotective Agents / chemistry ,Neuroprotective Agents ,030220 oncology & carcinogenesis ,Antioxidant ,2019-20 coronavirus outbreak ,Anti-Infective Agents / pharmacology ,Antineoplastic Agents / chemistry ,Immunomodulatory ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Antineoplastic Agents ,03 medical and health sciences ,Nutraceutical ,Flavonoids / chemistry ,Hypoglycemic Agents ,Humans ,Hypoglycemic Agents / chemistry ,030304 developmental biology ,Flavonoids ,business.industry ,Antioxidants / pharmacology ,Anti-Infective Agents / chemistry ,lcsh:RZ201-999 ,Clinical trial ,Hypoglycemic Agents / pharmacology ,Flavonoids / pharmacology ,Complementary and alternative medicine ,chemistry ,Dietary Supplements ,business - Abstract
Several flavonoids have been recognized as nutraceuticals, and myricetin is a good example. Myricetin is commonly found in plants and their antimicrobial and antioxidant activities is well demonstrated. One of its beneficial biological effects is the neuroprotective activity, showing preclinical activities on Alzheimer, Parkinson, and Huntington diseases, and even in amyotrophic lateral sclerosis. Also, myricetin has revealed other biological activities, among them as antidiabetic, anticancer, immunomodulatory, cardiovascular, analgesic and antihypertensive. However, few clinical trials have been performed using myricetin as nutraceutical. Thus, this review provides new insights on myricetin preclinical pharmacological activities, and role in selected clinical trials. This work was partially supported by CONICYT PIA/APOYO CCTE AFB170007. N. Martins would like to thank the Portuguese Foundation for Science and Technology (FCT-Portugal) for the Strategic project ref. UID/BIM/04293/2013 and “NORTE2020 - Northern Regional Operational Program” (NORTE-01-0145- FEDER-000012).
- Published
- 2020
- Full Text
- View/download PDF